Arbutus Biopharma Corp (ABUS)
2.98
+0.09
(+3.11%)
USD |
NASDAQ |
May 17, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Shares Outstanding: 188.72M for April 30, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 30, 2024 | 188.72M |
March 31, 2024 | 180.19M |
March 25, 2024 | 180.17M |
March 01, 2024 | 179.49M |
December 31, 2023 | 169.87M |
November 03, 2023 | 167.70M |
September 30, 2023 | 167.70M |
August 01, 2023 | 167.56M |
June 30, 2023 | 166.92M |
May 02, 2023 | 166.13M |
March 31, 2023 | 165.13M |
March 27, 2023 | 165.07M |
February 28, 2023 | 162.57M |
December 31, 2022 | 157.46M |
November 08, 2022 | 156.47M |
September 30, 2022 | 152.71M |
August 02, 2022 | 149.95M |
June 30, 2022 | 148.79M |
May 03, 2022 | 148.73M |
March 31, 2022 | 148.73M |
March 28, 2022 | 148.73M |
March 03, 2022 | 148.64M |
March 02, 2022 | 149.80M |
January 06, 2022 | 149.73M |
December 31, 2021 | 144.99M |
Date | Value |
---|---|
November 03, 2021 | 136.43M |
November 02, 2021 | 135.27M |
October 18, 2021 | 136.03M |
October 07, 2021 | 113.20M |
September 30, 2021 | 111.43M |
August 03, 2021 | 99.16M |
June 30, 2021 | 98.86M |
May 03, 2021 | 97.55M |
April 07, 2021 | 97.50M |
March 31, 2021 | 97.41M |
March 03, 2021 | 96.75M |
December 31, 2020 | 90.84M |
November 05, 2020 | 84.91M |
September 30, 2020 | 85.78M |
August 27, 2020 | 84.07M |
August 05, 2020 | 80.91M |
July 24, 2020 | 81.97M |
June 30, 2020 | 72.42M |
May 08, 2020 | 68.96M |
April 23, 2020 | 70.13M |
March 31, 2020 | 70.13M |
March 02, 2020 | 70.11M |
December 31, 2019 | 64.78M |
December 19, 2019 | 63.28M |
October 31, 2019 | 56.85M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
56.85M
Minimum
Jul 31 2019
188.72M
Maximum
Apr 30 2024
122.05M
Average
136.03M
Median
Oct 18 2021
Shares Outstanding Benchmarks
Moderna Inc | 383.24M |
Pfizer Inc | 5.667B |
Regeneron Pharmaceuticals Inc | 110.19M |
Chimerix Inc | 89.63M |
Karyopharm Therapeutics Inc | 117.71M |